AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
LigoCyte Pharmaceuticals Collaborates With NIH To Develop Mucosal Vaccine.(National Institute of Allergy and Infectious Diseases)
2001 OCT 17 - (NewsRx.com & NewsRx.net) -- LigoCyte Pharmaceuticals Inc. has entered into a Cooperative Research and Development Agreement (CRADA) with the National Institute of Allergy and Infectious Diseases (NIAID) for the development and preclinical testing of a rabies DNA vaccine targeted to mucosal tissues in the nose and mouth.
Under the CRADA, LigoCyte will provide its proprietary M cell targeting technology, which the company believes offers significant advantages in the delivery of oral and nasal vaccines. The company will collaborate with Dr. Donald Lodmell at NIAID's Rocky Mountain Laboratories in Hamilton, Montana. LigoCyte and NIAID will each produce a component of the vaccine to be used in experimental oral and nasal vaccinations of mice at the NIAID.
"We are delighted to enter into this cooperative agreement with NIAID and to continue testing to demonstrate additional proof-of-concept data for our mucosal targeting program," said Dr. Robert Goodwin, executive vice president and chief operating ...
- LigoCyte Pharmaceuticals awarded an additional $2.3 M Department of Defense...
- News wire article from: Chemical Business Newsbase July 6, 2006 700+ words
...NewsBase - Press Release) LigoCyte Pharmaceuticals Inc (LigoCyte) has been...vaccine against Norovirus. LigoCyte Pharmaceuticals, established in 1998, is...treatment of inflammatory and infectious diseases.
- LigoCyte Pharmaceuticals Announces a Cooperative Research and Development...
- Press release article from: PR Newswire September 18, 2001 700+ words
...PRNewswire/ -- LigoCyte Pharmaceuticals, Inc. announced...of Allergy and Infectious Diseases (NIAID) for...to the virus. LigoCyte Pharmaceuticals applies its expertise...inflammatory and infectious diseases, and is developing...
- LigoCyte Pharmaceuticals Presents Data Showing Heterosubtypic Protection...
- Press release article from: PR Newswire May 2, 2007 700+ words
...1 /PRNewswire/ -- LigoCyte Pharmaceuticals presented preclinical...National Foundation of Infectious Diseases in Baltimore. The current...prevention and treatment of infectious diseases and inflammation. The...Communications of LigoCyte Pharmaceuticals, Inc., +1-406...
- LigoCyte Pharmaceuticals receives $4.6 M NIH biodefense challenge grant for...
- News wire article from: Asia Africa Intelligence Wire October 3, 2005 700+ words
...NewsBase - Press Release) LigoCyte Pharmaceuticals (LigoCyte) have been awarded...installations worldwide. LigoCyte Pharmaceuticals, established in 1998, has...prevention of inflammatory and infectious diseases.
- LigoCyte Pharmaceuticals Receives $4.6M NIH Biodefense Challenge Grant for...
- Press release article from: PR Newswire October 3, 2005 700+ words
...3 /PRNewswire/ -- LigoCyte Pharmaceuticals announced today that they...prevention of inflammatory and infectious diseases. LigoCyte's world...CONTACT: Karen Sipes of LigoCyte Pharmaceuticals, +1-406-556-9228...
- LigoCyte Pharmaceuticals Awarded Additional $2.1M Department of Defense...
- Press release article from: PR Newswire June 25, 2004 700+ words
...June 25 /PRNewswire/ -- LigoCyte Pharmaceuticals, Inc. announced today that they...prevention of inflammatory and infectious diseases. The company's immunomodulatory...Marketing and Communications of LigoCyte Pharmaceuticals, Inc., +1-406-585-2733...
- LigoCyte Pharmaceuticals Executes Norovirus Vaccine Agreement With Baylor...
- Press release article from: PR Newswire May 25, 2004 700+ words
...Mont., May 25 /PRNewswire/ -- LigoCyte Pharmaceuticals, Inc. announced today that they...prevention of inflammatory and infectious diseases. The company's immunomodulatory...Marketing and Communications of LigoCyte Pharmaceuticals, Inc., +1-406-585-2733...
- LigoCyte Pharmaceuticals Awarded an Additional $2.3M Department of Defense...
- Press release article from: PR Newswire July 6, 2006 700+ words
...Mont., July 6 /PRNewswire/ -- LigoCyte Pharmaceuticals, Inc. announced today that they...the treatment of inflammatory and infectious diseases. The company has produced a number...Marketing and Communications of LigoCyte Pharmaceuticals, Inc., +1-406-556-9228...
- LigoCyte Pharmaceuticals Welcomes Don Beeman as New CEO.
- Press release article from: PR Newswire May 18, 2006 700+ words
...18 /PRNewswire/ -- LigoCyte Pharmaceuticals announced today that Donald...treatment of inflammatory and infectious diseases. The company has produced...and Communications of LigoCyte Pharmaceuticals, Inc., +1-406...
- LigoCyte Pharmaceuticals Initiates U.S. Clinical Trial of Norovirus Vaccine.
- Press release article from: PR Newswire April 3, 2007 700+ words
...April 3 /PRNewswire/ -- LigoCyte Pharmaceuticals, Inc. announced today that it...the prevention and treatment of infectious diseases and inflammation. LigoCyte is...Marketing & Communications of LigoCyte Pharmaceuticals, Inc., +1-406-556-9228...
Source: HighBeam Research, LigoCyte Pharmaceuticals Collaborates With NIH To Develop Mucosal...